| 1 |
Wang L, Wang W, Zhang L, Li J, Sun J, Wang S, Mao X. Simultaneous screening of multiple diarrhetic shellfish poisons with group-specific split aptamers and silver nanocluster beacon. Food Chem 2023;410:135389. [PMID: 36623457 DOI: 10.1016/j.foodchem.2023.135389] [Reference Citation Analysis]
|
| 2 |
Razlansari M, Jafarinejad S, rahdar A, Shirvaliloo M, Arshad R, Fathi-karkan S, Mirinejad S, Sargazi S, Sheervalilou R, Ajalli N, Pandey S. Development and classification of RNA aptamers for therapeutic purposes: an updated review with emphasis on cancer. Mol Cell Biochem 2022. [DOI: 10.1007/s11010-022-04614-x] [Reference Citation Analysis]
|
| 3 |
Rezaei N, Shahriari M, Mehrnejad F. Recent developments of nanomedicine delivery systems for the treatment of pancreatic cancer. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.104042] [Reference Citation Analysis]
|
| 4 |
Madani F, Esnaashari SS, Webster TJ, Khosravani M, Adabi M. Polymeric nanoparticles for drug delivery in glioblastoma: State of the art and future perspectives. J Control Release 2022;349:649-61. [PMID: 35878729 DOI: 10.1016/j.jconrel.2022.07.023] [Reference Citation Analysis]
|
| 5 |
Arévalo AP, Castelli R, Ibarra M, Crispo M, Calzada V. In Vivo Evaluation of Sgc8-c Aptamer as a Molecular Imaging Probe for Colon Cancer in a Mouse Xenograft Model. Int J Mol Sci 2022;23:2466. [PMID: 35269608 DOI: 10.3390/ijms23052466] [Reference Citation Analysis]
|
| 6 |
Parakh S, Nicolazzo J, Scott AM, Gan HK. Antibody Drug Conjugates in Glioblastoma - Is There a Future for Them? Front Oncol 2021;11:718590. [PMID: 34926242 DOI: 10.3389/fonc.2021.718590] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 7 |
Arshad R, Fatima I, Sargazi S, Rahdar A, Karamzadeh-Jahromi M, Pandey S, Díez-Pascual AM, Bilal M. Novel Perspectives towards RNA-Based Nano-Theranostic Approaches for Cancer Management. Nanomaterials (Basel) 2021;11:3330. [PMID: 34947679 DOI: 10.3390/nano11123330] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 8 |
Zhang Y, Sun C, Wang C, Jankovic KE, Dong Y. Lipids and Lipid Derivatives for RNA Delivery. Chem Rev 2021;121:12181-12277. [DOI: 10.1021/acs.chemrev.1c00244] [Cited by in Crossref: 94] [Cited by in F6Publishing: 57] [Article Influence: 47.0] [Reference Citation Analysis]
|
| 9 |
Shigdar S, Schrand B, Giangrande PH, de Franciscis V. Aptamers: Cutting edge of cancer therapies. Mol Ther 2021;29:2396-411. [PMID: 34146729 DOI: 10.1016/j.ymthe.2021.06.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 10 |
Dymova MA, Kuligina EV, Richter VA. Molecular Mechanisms of Drug Resistance in Glioblastoma. Int J Mol Sci 2021;22:6385. [PMID: 34203727 DOI: 10.3390/ijms22126385] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 11 |
Tian Z, Liang G, Cui K, Liang Y, Wang Q, Lv S, Cheng X, Zhang L. Insight Into the Prospects for RNAi Therapy of Cancer. Front Pharmacol 2021;12:644718. [PMID: 33796026 DOI: 10.3389/fphar.2021.644718] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 12 |
Amero P, Khatua S, Rodriguez-Aguayo C, Lopez-Berestein G. Aptamers: Novel Therapeutics and Potential Role in Neuro-Oncology. Cancers (Basel) 2020;12:E2889. [PMID: 33050158 DOI: 10.3390/cancers12102889] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 13 |
Brancato V, Nuzzo S, Tramontano L, Condorelli G, Salvatore M, Cavaliere C. Predicting Survival in Glioblastoma Patients Using Diffusion MR Imaging Metrics-A Systematic Review. Cancers (Basel) 2020;12:E2858. [PMID: 33020420 DOI: 10.3390/cancers12102858] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
